investing
Royalty Streaming: A Different Way to Get Exposure to the Cannabis Market
When cannabis legalization started to gain momentum in 2012 with Washington and Colorado legalizing recreational marijuana, everyone knew it was going to be a big industry. For nearly a decade now, the investment community has ridden the volatility of the emerging market that generated $13.8 billion in sales in North America in 2019. Analysts […]
Next Green Wave: A Hidden Gem in the Cannabis Industry
The cannabis industry is projected to hit $30 billion in sales by 2023, according to Marijuana Business Daily, with California representing about 34% of U.S. sales. While there are many publicly traded companies in the space, there are only a handful that are growing and profitable with a truly experienced team both in the […]
Der Psychedelika-Markt wird oft mit Wörtern, wie “aufstrebend”, “aufkeimend” und ähnlichen beschrieben, und obwohl dies sicherlich weitgehend zutrifft, sollten Anleger keinen Moment denken, dass dies alles neu ist. Das Gegenteil ist der Fall. Es gibt eine Vielzahl klinischer und präklinischer Daten, die vor dem Inkrafttreten des Gesetzes über kontrollierte Substanzen im Jahr 1970 gesammelt wurden. […]
MagicMed: Bringing the Drug Candidate Library Model to Psychedelics
The psychedelics market is often described as “emerging”, “burgeoning”, and other similar words, and while certainly true to a large extent, investors shouldn’t think for a moment this is all new. It’s far from it. There are scores of clinical and preclinical data to leverage, most collected before the Controlled Substance Act was enacted in […]
Tryp Debuts on the Canadian Securities Exchange
Tryp Therapeutics Inc. (CSE: TRYP) began trading on the Canadian Securities Exchange (CSE) on December 18, 2020 under the ticker symbol “TRYP”. “Trading on the CSE is a significant milestone in Tryp’s mission to transform the treatment of neuropsychiatric diseases with safe and effective psychedelic medicine,” said CEO James Kuo, MD. “All of the […]
Innovation zahlt sich aus bei Psychedelika
Es besteht ein erhebliches Interesse am psychedelischen Bereich und an den vielversprechenden psychedelischen Molekülen für die Behandlung von psychischen Erkrankungen. Geisteskrankheiten sind eine allgegenwärtige menschliche Erfahrung und eine bisher nur unzureichend behandelte medizinische Notwendigkeit. Psychedelika bieten eine Alternative zu unwirksamen Behandlungen, da sie über andere Wirkmechanismen funktionieren. Psychedelische Arzneimittel müssen jedoch verbessert werden, um aus […]
HempFusion Prepares to Go Public as a Unique Play on CBD
Charlotte’s Web Holdings Inc. (TSX: CWEB) bought Abacus Health Products Inc. in a stock transaction worth about $100 million last June. With competition on the rise in the CBD industry, Abacus provided Charlotte’s Web with a portfolio of over-the-counter (OTC) topical products that combined active pharmaceutical ingredients with hemp extracts. HempFusion Inc. (TSX: CBD.U – […]
Just How Large is the Psychedelics Market?
The psychedelics industry may appear to have suddenly emerged as one of the hottest corners of the stock market, but researchers have been working for decades to show the efficacy of these treatments and regulators are just starting to appreciate the possibilities. Investors could see strong growth in the industry as companies commercialize breakthrough therapeutics […]
How to Invest in the Rise of Cannabis-Infused Beverages
The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry has evolved to provide a growing array of different products, including tinctures, topicals, edibles—and beverages. Let’s […]
CB Therapeutics: Producing Rare Cannabinoid & Psychedelic Molecules at Scale
The cannabis industry has evolved from the legalization of dried cannabis to an increasingly detailed understanding of individual cannabinoids. While THC and CBD are the two most common, researchers are increasingly interested in CBC, THCV and other rare cannabinoids that could have specific and desirable effects on certain medical indications. The problem is that these […]
MagicMed Shortcuts Commercialization Timeline with University Agreement
Most pharmaceutical and biotech investors are familiar with long commercialization timelines, but there are a few ways to shortcut the process. For example, the Food and Drug Administration provides Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review designations for certain therapies targeting life-threatening conditions. MagicMed Industries Inc., a developer of licensable psychedelic molecular derivatives, […]
ManifestSeven: From Railroads to Fiber in California’s Cannabis Industry
California has the world’s largest cannabis market with an estimated $12 billion in annual sales. While legal cannabis sales topped $3 billion last year, the state continues to struggle to meet high expectations with logistical and other challenges. ManifestSeven Holdings Corporation (CSE: MSVN), which recently debuted on the Canadian Securities Exchange on September 30, aspires […]
CB Therapeutics Targets Psychedelics & Cannabis Markets
There’s little question that the market for cannabinoids and psychedelics are poised to experience significant growth over the coming years. While the demand for cannabinoids, like cannabidiol (CBD), has already seen tremendous growth, psychedelics represent a blue-sky market due to the potential to treat a wide range of mental health disorders. Let’s take a look […]
Wie der Psybrary ™ die Entdeckung psychedelischer Medikamente revolutionieren könnte Teilen
Laut Data Bridge Market Research wird der Markt für Psychedelika in den nächsten acht Jahren voraussichtlich mit einer durchschnittlichen jährlichen Wachstumsrate von 16,3% wachsen und bis 2026 6,85 Mrd. USD erreichen. Mit der Perspektive, eine breite Palette von psychischen Störungen zu behandeln führen bereits mehrere Organisationen klinische Studien in diesem Bereich durch. Werfen wir einen […]
Why Location Matters in Cannabis
The global cannabis industry has projected to be worth $73.6 billion by 2027, according to Grand View Research, which represents a blistering 18.1% compound annual growth rate. While cannabis has historically been grown indoors, outdoor cultivation has become increasingly popular over the past couple of years. Let’s take a look at the benefits of outdoor […]
MindLeap Health Enters into Fast-Growing Telehealth Market
The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes have created an enormous opportunity for companies to innovate in the remote delivery of health services. […]
DENVER, Sept. 24, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (MYCO.CN) (MYCOF) (0NF.F) (“Mydecine” or the “Company”), is pleased to announce that its subsidiary Mindleap Health’s (“Mindleap” ) telehealth platform will be officially available for download from the iOS and Android stores on September 30, 2020. Mindleap was founded with the goal of enhancing […]
Cybin Corp.: A Psychedelics Pioneer Led by a Biotech Veteran
Cybin has become one of the most popular psychedelic companies over the past year. With a unique approach to the market and an experienced management team, the company aims to bring a breakthrough psychedelic therapy to market for those suffering from Major Depressive Disorder and other mental health conditions—and build value for shareholders in the […]
MagicMed Closes Oversubscribed $1.6M Private Placement to Build Out Its Psybrary™
The burgeoning psychedelics sector in many ways resembles the cannabis industry of a decade ago. With rising interest in psychedelic medicine, analysts project that the market could grow at a 16.3% compound annual growth rate to $6.85 billion by 2027. There are a growing number of companies participating in the industry, most of which […]
Pilze zu Pillen: Wie Psychedelika auf den Markt kommen werden
Psychedelika so wie Psilocybin haben eine lange Geschichte der medizinischen Anwendung. In den 1950er Jahren wurden Psychedelika für kurze Zeit in der Psychologie und Psychiatrie geschätzt, bevor ein gesetzliches Verbot Mitte der 1960er Jahre die Forschung stoppte. In den 1990er Jahren gab es erneut Forschungsinteresse, aber erst mit der Legalisierung von Cannabis ging es wieder […]
Red White & Bloom: Scaling Up through Smart Acquisitions
More than 80 percent of mergers and acquisitions fail to boost shareholder value, according to KPMG, often due to lofty valuations, incompatible cultures, excessive risk, or a combination of these factors. Of course, the cannabis industry has been no exception judging by the $835 million iAnthus/MPX merger and Cresco Labs’ acquisition of Origin House. Companies that manage to beat […]
MagicMed möchte Partnern bei der Entwicklung von Psychedelika in Pharmaqualität helfen
Durch die zunehmende Verbreitung von psychischen Erkrankungen und die steigende Akzeptanz von Psychedelika zur Behandlung dieser Krankheiten, rechnet das Data Bridge Market Research Zentrum mit einer durchschnittlichen jährlichen Wachstumsrate in der Psychedelika-Industrie von 16,3% auf 6,85 Mrd. USD. Mit mehr als 15 börsennotierten Unternehmen haben Anleger eine immer mehr Optionen, in diesem Bereich. MagicMed Industries […]
Pure Extracts Enters Functional Mushroom Space Backstopped by Expertise in Cannabis Extraction
There are only a few times that investors get an opportunity to get in front of an emerging industry. Think about cannabis or electric vehicles in recent times. There can be tremendous upside, but there is generally a steep learning curve because the markets are so nascent and unique that everything is a […]
CFN Enterprises (OTCQB: CNFN) Names BlockChain Pioneer Tim Vasko to Board of Advisors
“We are pleased to welcome Tim Vasko, the Founder and CEO of BlockCerts Blockchain, to the Board of Advisors of CFN Enterprises. Tim is a cloud and blockchain pioneer, creating companies that have processed billions of transactions, proprietary tracking applications and a patent providing secure virtual spaces,” said Brian Ross, Chairman and CEO of CFN Enterprises Inc.
CBG Spells Hope for Patients and Sales for Hemptown USA
Neurodegenerative diseases like Huntington’s and Parkinson’s come with grim prognoses, slowly debilitating a patient year after year with little doctors can do to slow, much less arrest, progression. Research is still in the early stages, but there is reason to be optimistic that a little known part of cannabis and hemp could one day provide […]
3 Sixty Secure Corp. and MJardin Announce Protective Services and Secure Transport Agreement
ALMONTE, ON, Jan. 31, 2019 /CNW/ – 3 Sixty Risk Solutions Ltd. (“3Sixty” or the “Company“) (CSE: SAFE) is pleased to announce that the Company, which operates through its wholly-owned subsidiary, 3 Sixty Secure Corp., has entered into a multi-year, service agreement to provide guarding and secure transport services to an affiliate of MJardin Group, Inc. […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Cannafornia is a California-based cultivator, manufacturer and supplier of high-quality hand-crafted cannabis and cannabis products.
CannaTrac® is dedicated to bringing safety to the cannabis industry by serving as the industry’s leading cashless mobile payment system solution. CannaTrac® created the CannaCard® and the CannaCard App™ to provide consumers and retailers with a convenient way to benefit from increased safety and convenience through cashless purchases within the legal cannabis industry.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
